Going against type: the new class of cancer therapies targeting mutations rather than tissues ‘Tumour agnostic’ drugs offer a more effective and tolerable therapy for a wide range of people with cancer, so why has the NHS rejected its first one?…
Understanding irritable bowel syndrome: bugs, brains and leaky barriers Research indicates that there are multiple causes for the symptoms of irritable bowel syndrome, and that most of them may involve the microbiome.…
